FDA NDC Directory · JSON-LD · Markdown

Baxdela

NDC 70842-102 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic namedelafloxacin meglumine
Labeler / ManufacturerMelinta Therapeutics, LLC
Marketing categoryNew Drug Application (innovator) · App NDA208611
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsDELAFLOXACIN MEGLUMINE (300 mg/10.5mL)
Marketing started20170619
Package count1

External sources

Source: openFDA. Public-domain (CC0).